Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Coulouarn C et al. – miR–122 is a marker of hepatocyte–specific differentiation and an important determinant in the control of cell migration and invasion. From a clinical point of view, the study emphasizes miR–122 as a diagnostic and prognostic marker for HCC progression.

Related Articles

MiR-122 affects the viability and apoptosis of hepatocellular carcinoma cells
Scandinavian Journal of Gastroenterology, 11/06/09    Relevance Score: 65%

Expression analysis of Notch-related molecules in peripheral blood T helper cells of patients with rheumatoid arthritis
Scandinavian Journal of Rheumatology, 10/01/09    Relevance Score: 48%

GPR30 and estrogen receptor expression: New insights into hormone dependence of inflammatory breast cancer
Breast Cancer Research and Treatment, 11/16/09    Relevance Score: 47%

Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody
Breast Cancer Research and Treatment, 11/04/09    Relevance Score: 47%

MicroRNA expression, survival, and response to Interferon in liver cancer
New England Journal of Medicine, 10/08/09    Relevance Score: 47%

Today in Hepatobiliary/Pancreas...keeping you current

Hepatoblastoma metastatic to the right atrium responding to chemotherapy alone
Pediatric Hematology and Oncology, 11/25/09

Expression of IL-13Ralpha2 in liver cancer cells and its effect on targeted therapy of liver cancer
Journal of Cancer Research & Clinical Oncology, 11/23/09

L1 Cell Adhesion Molecule Is a Novel Independent Poor Prognostic Factor of Extrahepatic Cholangiocarcinoma
Clinical Cancer Research, 11/20/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address